James Whyte > 8 New Square Intellectual Property > London, England > Lawyer Profile

8 New Square Intellectual Property
8 New Square


Barrister specialising in intellectual property law, with a particular emphasis on technically complex patent cases in biotechnology, pharmaceuticals, telecoms and electronics. Scheduled trials include Gilead v NuCana (nucleotide derivatives), InterDigital v OnePlus (telecoms), Abbott v DexCom (glucose sensors), Novartis v BioEq (syringes), Siemens v GE (wind turbines). Recent cases include InterDigital v Lenovo (telecoms), Optis v Apple (telecoms), Insulet v Roche (insulin pumps), Royalty Pharma v Boehringer Ingelheim (royalty dispute under German law), GSK v Fibrogen (iron deficiency drugs; settled shortly before trial), ABI v Heineken (blow moulded containers; settled shortly before trial), Conversant v Huawei (telecoms), Illumina v Ariosa (cell-free foetal DNA enrichment), Silence v Alnylam (RNAi; settled shortly before trial), Pacific Biosciences v Oxford Nanopore (DNA sequencing; settled shortly before trial), Chugai v UCB Pharma (US antibody engineering patent), Illumina v Premaitha (prenatal diagnosis), Regeneron v Kymab (antibody engineering).


Called 2005, Lincoln’s Inn.


Chancery Bar Association, IP Bar Association.


BA in Natural Sciences (1st), Cambridge; PhD in molecular cell biology, Cambridge; postgraduate diploma in law (distinction), City University; bar vocational course (outstanding), BPP.

Lawyer Rankings

London Bar > Intellectual property

(Leading Juniors)Ranked: Tier 1

James Whyte8 New Square

Housing ‘excellent barristers at all levels of qualification‘, 8 New Square is consistently involved in the market’s most significant IP-related litigation, its expertise covering all aspects of patents, copyright and trade marks. Well known for his work in high-tech patent litigation, James Abrahams KC represented Lenovo in a major standards essential patent case that involved multiple trials, and 3G and 4G mobile phone technology issues; and Lindsay Lane KC has particular expertise in patents and supplementary protection certificates, trade marks, copyright, database rights, designs, passing off, and confidential information. At the set’s senior-junior end, James Whyte represented Boehringer Ingelheim International in a significant patent licensing dispute, which raised issues of German second medical use patent law and German contract law. In a boost to chambers, patent specialist James St. Ville KC took silk in March 2022.